RXST
RxSight, Inc.Company Information
- Company Name
- RxSight, Inc.
- CIK
- CIK0001111485
- Category
- Accelerated filer
- Ticker: Exchange
- RXST: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3851
- SIC Description
- Ophthalmic Goods
- Ticker
- RXST
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-01-16
- Last sale
- 2026-09-02
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 16,947
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 39,427,118
- Shares outstanding
- 41,490,889
- Ownership
- 95.03%
Earnings Market Reaction
- Filing date
- 2026-08-05
- Price on filing date
- —
- 1-month reaction
- 12.08%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 13 | 18 | 20 | 30 | 40 | 28 | 17 | 17 | 24 | 33 | 10 | 10 | ||||||
| Short Term Investments | 195 | 200 | 208 | 198 | 187 | 201 | 221 | 220 | 209 | 93 | 117 | 122 | ||||||
| Accounts Receivable Net Current | 19 | 22 | 23 | 24 | 28 | 31 | 30 | 25 | 26 | 22 | 20 | 15 | ||||||
| Inventory Net | 37 | 35 | 32 | 29 | 25 | 24 | 22 | 22 | 19 | 19 | 17 | 19 | ||||||
| Prepaid Expense And Other Assets Current | 3 | 4 | 4 | 3 | 3 | 5 | 5 | 3 | 3 | 3 | 4 | 2 | ||||||
| Other Receivables Net Current | 60 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Assets Current | 327 | 279 | 287 | 284 | 284 | 288 | 294 | 287 | 281 | 169 | 168 | 168 | ||||||
| Property Plant And Equipment Net | 14 | 13 | 13 | 13 | 13 | 13 | 12 | 12 | 12 | 12 | 11 | 10 | ||||||
| Operating Lease Right Of Use Asset | 9 | 10 | 10 | 10 | 11 | 11 | 11 | 11 | 11 | 2 | 2 | 3 | ||||||
| Restricted Cash Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Other Assets Noncurrent | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 353 | 304 | 312 | 309 | 309 | 313 | 319 | 310 | 305 | 183 | 183 | 182 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 6 | 7 | 5 | 3 | 3 | 7 | 5 | 5 | 5 | 5 | 4 | 4 | ||||||
| Accrued Liabilities And Other Liabilities | 16 | 19 | 20 | 18 | 16 | 15 | 20 | 17 | 14 | 12 | 15 | 13 | ||||||
| Deferred Revenue Current | 7 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Customer Refund Liability Current | 50 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities Current | 80 | 27 | 26 | 22 | 20 | 23 | 26 | 23 | 20 | 18 | 21 | 19 | ||||||
| Liabilities Other Than Longterm Debt Noncurrent | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Long Term Debt | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Liabilities | 89 | 37 | 36 | 33 | 31 | 34 | 37 | 33 | 30 | 19 | 22 | 20 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 952 | 944 | 937 | 928 | 920 | 910 | 903 | 893 | 885 | 768 | 755 | 747 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | 0 | 0 | -0 | 0 | 0 | 1 | -0 | -0 | -0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -689 | -677 | -661 | -652 | -642 | -630 | -622 | -616 | -610 | -604 | -595 | -585 | ||||||
| Stockholders Equity | 263 | 267 | 276 | 276 | 278 | 279 | 281 | 277 | 275 | 164 | 160 | 161 | ||||||
| Liabilities And Stockholders Equity | 353 | 304 | 312 | 309 | 309 | 313 | 319 | 310 | 305 | 183 | 183 | 182 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 900 | 900 | 900 | 900 | 900 | 900 | 900 | 900 | 900 | 900 | 900 | 900 | ||||||
| Common Stock Shares Issued | 42 | 41 | 41 | 41 | 41 | 41 | 40 | 40 | 40 | 37 | 36 | 36 | ||||||
| Shares Outstanding | 42 | 41 | 41 | 41 | 41 | 41 | 40 | 40 | 40 | 37 | 36 | 36 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialRxSight, Inc. (RXST) — SEC Financial Statements & Analysis
RxSight, Inc. (RXST) is a ophthalmic goods company, incorporated in DE. RxSight, Inc. trades on Nasdaq as: RXST. RxSight, Inc. (RXST)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, RxSight, Inc. carries a market cap of $199.99M, a P/E ratio of -4.26x, a P/B ratio of 0.76x, a P/S ratio of 1.57x, an enterprise value of $185.88M, and an EV/EBITDA multiple of -3.60x. On profitability, it posts a gross margin of 77.50%, an operating margin of -43.20%, a net margin of -36.80%, a Return on Equity (ROE) of -17.35%, a Return on Assets (ROA) of -14.19%, and a Return on Invested Capital (ROIC) of -22.42%. Per share, it reports EPS of $-1.13, diluted EPS of $-1.13, free cash flow per share of $-0.65, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -13.25% year-over-year, net income growth of 45.57% year-over-year, and EPS growth of 42.95% year-over-year. On the balance sheet, it maintains a current ratio of 4.07x, a quick ratio of 3.57x, working capital of $246.95M, a debt-to-equity ratio of 0.34x, a debt ratio of 0.25, an interest coverage ratio of -3936.64x, free cash flow of $-27.16M (TTM), and net debt of $-14.10M. Figures sourced from SEC EDGAR.
- Market Cap
- $199.99M
- P/E TTM
- -4.26x
- EPS TTM
- $-1.13
- P/B TTM
- 0.76x
- ROE TTM
- -17.35%
- ROA TTM
- -14.19%
- Debt To Equity
- 0.34x
- Free Cash Flow TTM
- $-27.16M
- Net Revenue TTM Growth 1Y
- -13.25%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is RxSight, Inc. in?
RxSight, Inc. (RXST) operates in the Ophthalmic Goods industry.
What exchange does RXST trade on?
RxSight, Inc. (RXST) trades on the Nasdaq.
Where is RxSight, Inc. incorporated?
RxSight, Inc. is incorporated in DE.
When was RxSight, Inc. (RXST)'s most recent SEC filing?
RxSight, Inc. (RXST)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05.
What is RXST's market cap?
RxSight, Inc. (RXST) has a market capitalization of $199.99M as of 2026-06-30.
What is RXST's EPS (earnings per share)?
RxSight, Inc. (RXST)'s trailing twelve month EPS is $-1.13 as of 2026-06-30.
What is RXST's ROE (return on equity)?
RxSight, Inc. (RXST)'s trailing twelve month Return on Equity (ROE) is -17.35% as of 2026-06-30.
What is RXST's ROA (return on assets)?
RxSight, Inc. (RXST)'s trailing twelve month Return on Assets (ROA) is -14.19% as of 2026-06-30.
What is RXST's ROIC (return on invested capital)?
RxSight, Inc. (RXST)'s trailing twelve month Return on Invested Capital (ROIC) is -22.42% as of 2026-06-30.
What is RXST's EV/EBITDA?
RxSight, Inc. (RXST)'s trailing twelve month EV/EBITDA is -3.60x as of 2026-06-30.